• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Norm MacIsaac, Canada

      Norm MacIsaac, Canada

    • Michael Lee, Australia

      Michael Lee, Australia

    • Fernando Ocampo Cardona, Colombia

      Fernando Ocampo Cardona, Colombia

    • Oscar Mauricio Linares, Colombia

      Oscar Mauricio Linares, Colombia

    • Horacio Fritzer, Argentina

      Horacio Fritzer, Argentina

    • Luis Antonio Pimenta Lima, Brazil

      Luis Antonio Pimenta Lima, Brazil

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • Anita Forte, USA

      Anita Forte, USA

    • Mike Small, UK

      Mike Small, UK

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Sam Hayden-Harler, UK

      Sam Hayden-Harler, UK

    • Conny van der Meijden, Netherlands

      Conny van der Meijden, Netherlands

    • Armando González Gómez, Colombia

      Armando González Gómez, Colombia

    • Chun Ju Xiao, China

      Chun Ju Xiao, China

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Ana Lilia Rodriguez, Mexico

      Ana Lilia Rodriguez, Mexico

    • Ada Garrido Benavidez, Mexico

      Ada Garrido Benavidez, Mexico

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • João Marcos Andrietta, Brazil

      João Marcos Andrietta, Brazil

    • David Solomon, UK

      David Solomon, UK

    • Marcelo Farinelli, Brazil

      Marcelo Farinelli, Brazil

    • Andrea Zicchieri, Italy

      Andrea Zicchieri, Italy
      AndreaZicchieri_conSLAncioItaly

    • Stephanie Christiansen Hall, Canada

      Stephanie Christiansen Hall, Canada

    • Ali Var, Turkey

      Ali Var, Turkey

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Sally Pauls, USA

      Sally Pauls, USA

    • Yolanda Armendariz, Mexico

      Yolanda Armendariz, Mexico

    • Lee Millard, England

      Lee Millard, England

    • Lin Yong Yi, Taiwan

      Lin Yong Yi, Taiwan

    • Sébastien Batiot, France

      Sébastien Batiot, France

    • Chirag Walia, India

      Chirag Walia, India
      ChiragWalia

    • Jose Espinosa, Argentina

      Jose Espinosa, Argentina

    • Irene McCaughey, Australia

      Irene McCaughey, Australia

    • Mark Miller, UK

      Mark Miller, UK

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Jorge Luis Fernández Romero, Mexico

      Jorge Luis Fernández Romero, Mexico

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • JP

      JP

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • PALS and CALS, Singapore

      PALS and CALS, Singapore

    • Lombana, Spain

      Lombana, Spain

    • John Dinon, Australia

      John Dinon, Australia

    • Daniel Hare, USA

      Daniel Hare, USA

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • Shera Mukherjee, India

      Shera Mukherjee, India

    • Carlos Gomez Matallanas, Spain

      Carlos Gomez Matallanas, Spain

    • Barry de Reuver, Netherlands

      Barry de Reuver, Netherlands

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login